An investigation of oxidative stress and coenzyme Q10 levels in patients with head and neck squamous cell carcinomas

  • Ahmet AksoyEmail author
  • Senem Çengel Kurnaz
Head & Neck



The purpose of this study was to determine the oxidative states of head and neck squamous cell carcinoma (HNSCC) patients by measuring their plasma levels of malondialdehyde (MDA), an indicator of lipid peroxidation, 3-nitrotyrosine (3-NT), an indicator of protein oxidation, and the coenzyme Q10 (CoQ10), an important antioxidant, and compare them with healthy individuals.

Materials and methods

The plasma MDA, 3-NT and CoQ10 levels of 35 patients and 20 healthy individuals were measured with the high-performance liquid chromatography (HPLC) method. By comparing the patients’ smoking habits, stage of the disease, size of the primary tumor and the presence of lymph nodes and the values of healthy individuals, the oxidative stress load of HNSCC patients was determined.


The mean plasma MDA levels of carcinoma patients were two times higher than those of healthy individuals (p < 0.001). When the mean plasma 3-NT levels of patients and healthy individuals were compared, no significant difference was found (p > 0.05). The mean plasma CoQ10 level of patients was low when compared with healthy individuals; however, no significant difference was detected (p > 0.05). In addition, as the stage and tumor size increased in HNSCC patients, their non-enzymatic antioxidant levels significantly decreased (p < 0.05).


In HNSCC patients, lipo-oxidative damage increased while nitrosative stress did not change; however, antioxidant activity decreased which in turn increased both lipid peroxidation and oxidative stress. These findings support the contention that oxidative stress strongly reflects the health status of HNSCC patients.


Squamous cell carcinoma Coenzyme Q10 Malondialdehyde 3-Nitrotyrosine Oxidative stress 



This study was submitted as an oral presentation at the 35th Turkish National Otolaryngology—Head and Neck Surgery Congress on Novemder 2–6, 2013, in Antalya, Turkey. The authors thank Gregory Thomas Sullivan of the University of Queensland in Brisbane, Australia, for editing the English in an earlier version of this manuscript.


This study was funded as a Ondokuz Mayıs University Scientific Research Projects (projectnumber - TIP1904.12.030).

Compliance with ethical standards

Conflict of interest

The authors declare that there is no conflict related to this research.

Ethical approval

Ethics committee approval (2012/07) was received from Ondokuz Mayis University, Faculty of Medicine. All procedures performed in this study that involved human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    Brockstein B, Masters G (eds) (2003) Headand Neck Cancer. Kluwer Academic Publishers, Dordrecht pp 1–295. ISBN 1-4020-7336-4Google Scholar
  2. 2.
    Siddartha SB, Kumari S, Rathan S, Babu S, Shetty S (2011) Status of serum sialic acid, antioxidant and lipid peroxidation in head and neck cancer patients. Res J Pharma Biol Chem Sci 2(1):1–5Google Scholar
  3. 3.
    Nagal MA (1999) Genetic alterations in head and neck squamous cell carcinomas. Braz J Med Biol Res 32:897–904CrossRefGoogle Scholar
  4. 4.
    Chen YJ, Chang JTC, Liao CT, Wang HM, Yen TC, Chiu CC, Lu YC, Li HF, Cheng AJ (2008) Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci 99:1507–1514CrossRefGoogle Scholar
  5. 5.
    Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C (2007) Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 121:2381–2386CrossRefGoogle Scholar
  6. 6.
    Lobo V, Patil A, Phatak A, Chandra N (2010) Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev 4(8):118–126CrossRefGoogle Scholar
  7. 7.
    Sies H, Stahl W, Sundquist AR (1992) Antioxidant functions of vitamins; vitamins E and C, beta-carotene, and other carotenoids. Ann N Y Acad Sci 30(669):7–20CrossRefGoogle Scholar
  8. 8.
    Gupta A, Bhatt MLB, Misra MK (2009) Lipid peroxidation and antioxidant status in head and neck squamous cell carcinoma patients Oxid Med Cell Longev 2(2):68–72CrossRefGoogle Scholar
  9. 9.
    Rasheed HM, Beevi SS, Geetha A (2007) Enhanced lipid peroxidation and nitric oxide products with deranged antioxidant status in patients with head and neck squamous cell carcinoma. Oral Oncol 43:333–338CrossRefGoogle Scholar
  10. 10.
    Taysi S, Uslu C, Akcay F, Sütbeyaz MY (2003) Malondialdehyde and nitric oxide levels in the plasma of patients with advanced laryngeal cancer. Surg Today 33:651–654CrossRefGoogle Scholar
  11. 11.
    Dotan Y, Lichtenberg D, Pinchuk I (2004) Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog Lipid Res 43:200–227CrossRefGoogle Scholar
  12. 12.
    Hoff HF, O’Neil J (1993) Structural and functional changes in LDL after modification with both 4-hydroxynonenal and malondialdehyde. J Lipid Res 34:1209–1217Google Scholar
  13. 13.
    Salzman R, Pacal L, Kankova K, Tomandl J, Horakova Z, Tothova E, Kostrica R (2010) High perioperative level of oxidative stress as a prognostic tool for identifying patients with a high risk of recurrence of head and neck squamous cell carcinoma. Int J Clin Oncol 15:565–557CrossRefGoogle Scholar
  14. 14.
    Ischiropoulos H, Al-Mehdi AB (1995) Peroxynitrite-mediated oxidative protein modification. FEBS Lett 364:279–282CrossRefGoogle Scholar
  15. 15.
    Yaman H, Unlu A, Karabıcak U, Cimen B, Balabanlı B, Erbil MK, Torkozkan N (2000) Measurement of 3-Nitrotyrosine by high performance liquid chromatography. T Klin J Med Res 18:26–30Google Scholar
  16. 16.
    Gurkan AS, Dundar OB (2005) Coenzyme Q10. J Fac Pharm Ankara 34(2):129–154Google Scholar
  17. 17.
    Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC Cancer Staging Manual, 7th ed., Springer, New York, pp 21–100. ISBN 978-0-387-88440-0Google Scholar
  18. 18.
    Yoshioka T, Kawada K, Shimada T, Mori M (1979) Lipid peroxidation in maternal and cord blood and protective mechanism against actived-oxygen toxicity in the blood. Am J Obstet Gynecol 135(3):372–376CrossRefGoogle Scholar
  19. 19.
    Eraslan G, Saygi S, Essiz D, Aksoy A, Gul H, Macit E (2007) Evaluation of aspect of some oxidative stress parameters using vitamin E, proanthocyanidin and N-acetylcysteine against exposure to cyfluthrin in mice. Pestic Biochem Physiol 88:43–49CrossRefGoogle Scholar
  20. 20.
    Agarwal R, Chase SD (2002) Rapid, flurimetric-liquid chromatographic determination of malondialdehyde in biological samples. J Chromatogr B 775:121–126CrossRefGoogle Scholar
  21. 21.
    Chang SI, Jin B, Youn P, Park C, Park JD, Ryu DY (2007) Arsenic-induced toxicity and the protective role of ascorbic acid in mouse testis. Toxicol Appl Pharmacol 218:196–203CrossRefGoogle Scholar
  22. 22.
    Shariff AK, Patil SR, Shukla PS, Sontakke AV, Hendre AS, Gudur AK (2009) Effect of oral antioxidant supplementation on lipid peroxidation during radiotherapy in head and neck malignancies. Indian J Clin Biochem 24(3):307–311CrossRefGoogle Scholar
  23. 23.
    Fang YZ, Yang S, Wu G (2002) Free radicals, antioxidants, and nutrition. Nutrition 18:872–879CrossRefGoogle Scholar
  24. 24.
    NishaSachdeva A, Lal H (2008) Some oxidative stress related parameters in patients with head and neck carcinoma. Indian J Clin Biochem 23(1):38–40CrossRefGoogle Scholar
  25. 25.
    Canbay E, Celik K, Kunt T, Ertemur M, Canbay E (2002) An alteration in glutathione peroxidase activity and lipid peroxidation levels in patients with laryngeal carcinoma. Cumhuriyet MedicalJournal 24(4):175–178Google Scholar
  26. 26.
    Kaur J, Politis C, Jacobs R (2016) Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action. Clin Oral Investig 20(2):315–319. Epub 2015 Jun 17CrossRefGoogle Scholar
  27. 27.
    Murugaiyan SB, Ramasamy R, Nakkeeran M, Rangdhol V, Srinivasan AR, Niranjan G (2015) Urinary 8-hydroxydeoxyguanosine as a marker of oxidative stress induced genetic toxicity in oral cancer patients. Indian J Dent Res 26(3):226–230. CrossRefGoogle Scholar
  28. 28.
    Malathi M, Vijay M, Shivashankara AR (2011) The role of oxidative stress and the effect of radiotherapy on the plasma oxidant-antioxidant status in head and neck cancer J Clin Diagn Res 5(2):225–249Google Scholar
  29. 29.
    Mrowicka M, Zielińska-Bliźniewska H, Pietkiewicz P, Olszewski J, Majsterek I (2015) Evaluation of selected indicators of antioxidant status in patients with head and neck cancer. Otolaryngol Pol 69(5):44–50Google Scholar
  30. 30.
    Herce-Pagliai C, Kotecha S, Shuker DEG (1998) Analytical methods for 3-nitrotyrosine as a marker of exposure to reactive nitrogen species: a review. Nitric Oxide Biol Chem 2(5):324–336CrossRefGoogle Scholar
  31. 31.
    Bahar G, Feinmesser R, Shpitzer T, Popovtzer A, Nagler RM (2007) Salivary analysis in oral cancer patients: DNA and protein oxidation, reactive nitrogen species, and antioxidant profile. Cancer 109(1):54–59CrossRefGoogle Scholar
  32. 32.
    Dahiya K, Dhankhar R, Madaan H, Singh V, Arora K (2012) Nitric oxide and antioxidant status in head and neck carcinoma before and after radiotherapy. Ann Clin Lab Sci 42(1):94–97Google Scholar
  33. 33.
    Folkers K, Brown R, Judy WV, Morita M (1993) Survival of cancer patients on therapy with coenzyme Q10. Biochem Biophys Res Commun 192:241–245CrossRefGoogle Scholar
  34. 34.
    Folkers K, Osterborg A, Nylander M, Morita M, Mellstedt H (1997) Activities of vitamin Q10 in animal models and a serious deficiency in patients with cancer. Biochem Biophys Res Commun 234:296–299CrossRefGoogle Scholar
  35. 35.
    Portakal O, Özkaya Ö, İnal ME, Bozan B, Koşan M, İskender S (2000) Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. Clin Biochem 33(4):279–284CrossRefGoogle Scholar
  36. 36.
    Trueba GP, Sanchez GM, Giuliani A (2004) Oxygen free radical and antioxidant defense mechanism in cancer. Front Biosci 9:2029–2044CrossRefGoogle Scholar
  37. 37.
    Potgieter M, Pretorius E, Pepper MS (2013) Primary and secondary coenzyme Q10 deficiency: the role of therapeutic supplementation. Nutr Rev 71(3):180–188CrossRefGoogle Scholar
  38. 38.
    Gaby AR (1996) The role of coenzyme Q10 in clinical medicine: part-I. Alt Med Rev 1(1):11–17Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Otorhinolaryngology, Faculty of MedicineNigde UniversityMerkez/NigdeTurkey
  2. 2.Department of Otorhinolaryngology, Faculty of MedicineBahcesehir UniversityIstanbulTurkey

Personalised recommendations